Menu Back to CMC-Workshop-From-Drug-Development-to-Global-Supply-to-Patients

Program Committee

  • Yasmin  de Faria Krim, PharmD, MSc
    Yasmin de Faria Krim, PharmD, MSc Chair DIA CMC Working Group - Regulatory Affairs Community, France
  • Lin-Jau (Christine) Wu Anderson, MS, RAC
    Lin-Jau (Christine) Wu Anderson, MS, RAC Senior Research Scientist, Global Regulatory Affairs CMC Eli Lilly and Company, United States
  • Nagesh  Bandi, PhD
    Nagesh Bandi, PhD Director, Global CMC Pfizer Pharmaceuticals, Inc., United States
  • Ganapathy  Mohan, PhD
    Ganapathy Mohan, PhD Head of Global CMC Merck & Co., Inc., United States
  • Elaine  Morefield, PhD, RPh
    Elaine Morefield, PhD, RPh Senior Director, CMC Strategy, R&D Vertex Pharmaceuticals, United States
  • Peter  Richardson
    Peter Richardson Head of Quality, Human Medicines Evaluation Division European Medicines Agency, European Union, United Kingdom
  • Jean-Louis  Robert, PhD
    Jean-Louis Robert, PhD Head, Medicines Control Laboratory National Health Laboratory, Luxembourg
  • Thirunellai G Venkateshwaran, PhD
    Thirunellai G Venkateshwaran, PhD Senior Director and Global Head, Product Management - Marketed Products Hoffman La Roche Ltd., Switzerland
Load More